ARCHIVES

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

This article is from The Cancer Letter archive.

Vol. 15 No. 04 | January 27, 1989

Download PDF Visit The Full Archive

Related Articles

DCT Advisors OK Recompetition Of Drug Contacts

March 15, 1991

FDA Staff Failed To Explain Approval Standards, Correct Misconceptions.

April 13, 2007

Study Seeks Newly Diagnosed Prostate Cancer Patients

March 26, 2010

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

June 28, 2013

Obituary: Rajka Medenica, controversial Physician

December 5, 1997

Other ASCO Plenary Papers: Long Awaited Chemotherapy Results

June 12, 1992